Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

+44 1478 350008

Mycobacterial Diseases : Citations & Metrics Report

Articles published in Mycobacterial Diseases have been cited by esteemed scholars and scientists all around the world. Mycobacterial Diseases has got h-index 13, which means every article in Mycobacterial Diseases has got 13 average citations.

Following are the list of articles that have cited the articles published in Mycobacterial Diseases.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

115 113 61 44 13 7 20 21 34 23 41 19 32 10

Research, Review articles and Editorials

1 5 11 7 1 3 14 18 21 11 33 19 28 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

84 108 26 23 12 3 6 3 13 6 3 0 4 0

Conference proceedings

0 0 0 0 0 0 0 0 0 0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

31 55 63 98 74 131 120 127 103 74 13 10 3 4
Journal total citations count 923
Journal h-index 13
Journal h-index since 2019 10
Important citations (315)

aslam n, aslam b, yaqoob i. susceptibility pattern of mycobacterium tuberculosis to 1st line anti tuberculosis therapy. annals of punjab medical college (apmc). 2018:12(3);195-197.

dash m. microbiology: an international journal. 2016.

actor jk. effective screening for tuberculosis: the need of the hour. mycobact dis. 2016:6;e132.

solioz m. copper homeostasis in gram-negative bacteria. incopper and bacteria 2018:49-80.

pal p. research & reviews: journal of hospital and clinical pharmacy.

combrink m, du preez i, ronacher k, walzl g, loots dt. time-dependent changes in urinary metabolome before and after intensive phase tuberculosis therapy: a pharmacometabolomics study. omics: a journal of integrative biology. 2019:23(11);560-572.

tweed cd. toxicity related to the treatment of pulmonary tuberculosis (doctoral dissertation, ucl (university college london)).2019.

actor jk. effective screening for tuberculosis: the need of the hour. mycobact dis. 2016:6;e132.

dash m. microbiology: an international journal. 2016.

séraphin mn, norman a, rasmussen em, gerace am, chiribau cb, rowlinson mc, et al. direct transmission of within-host mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: a genomic investigation. ebiomedicine. 2019:47;293-300.

du preez i, loots dt. novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance. drug metabolism reviews. 2018:50(4);466-481.

tweed cd, crook am, amukoye ei, dawson r, diacon ah, hanekom m, et al. toxicity associated with tuberculosis chemotherapy in the remoxtb study. bmc infectious diseases. 2018:18(1);317.

actor jk. effective screening for tuberculosis: the need of the hour. mycobact dis. 2016:6;e132.

pal p. research & reviews: journal of hospital and clinical pharmacy.

radhika k, hemalatha s, maragatham s, kathrine sp. research and reviews: j agriculture and allied sciences. 2013.

dash m. microbiology: an international journal. 2016.

dash m. microbiology: an international journal. 2016.

dash m. microbiology: an international journal. 2016.

duan p, zheng q, lin z, wang s, chen d, liu w. molecular engineering of thiostrepton via single “base”-based mutagenesis to generate side ring-derived variants. organic chemistry frontiers. 2016:3(10);1254-1258.

du liping, wei dong, pan ning, tang yan, fu rong. investigation on the epidemic situation and control results of leprosy in liangshan prefecture, sichuan province. chinese j endemic dis cont. 2016:(4);374-376.      

Top